MindBio Therapeutics Corp
CNSX:MBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MindBio Therapeutics Corp
CNSX:MBIO
|
CA |
|
F
|
Farmacosmo SpA
MIL:COSMO
|
IT |
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
US |
Shareholder Yield
Current shareholder yield for MBIO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
MBIO Price
MindBio Therapeutics Corp
| Average Annual Return | -55.69% |
| Standard Deviation of Annual Returns | 50.47% |
| Max Drawdown | -98% |
| Market Capitalization | 6m CAD |
| Shares Outstanding | 4 790 000 |
| Percentage of Shares Shorted |
N/A
|
MBIO Return Decomposition
Main factors of price return
Stock Splits
MBIO's latest stock split occurred on Nov 6, 2025
The company executed a 1-for-400 stock split, meaning that for every 400 shares held, investors received 1 new share.
Before the split, MBIO traded at 2 per share. Afterward, the share price was about 2.
The adjusted shares began trading on Nov 6, 2025. This was the only stock split in MBIO's history.
